All News about Immunogen Inc
![](https://mms.businesswire.com/media/20220421005100/en/1426607/5/imgnlogo.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_6635.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220401005334/en/1408165/5/imgnlogo.jpg)
From ImmunoGen, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2012/aapharma_3911.png?width=1200&height=800&fit=crop)
Why Are ImmunoGen Shares Trading Lower Today
March 21, 2022
Via Benzinga
![](https://mms.businesswire.com/media/20220331005315/en/1406297/5/imgnlogo.jpg)
![](https://cdn.benzinga.com/files/images/story/2012/cells-gdd37bc5d2_1920_19.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220329005270/en/1403087/5/imgnlogo.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_416.png)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_4771.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_4750.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/analyst_ratings_image_5144.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_144.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_4720.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_577.png)
![](https://mms.businesswire.com/media/20220319005002/en/1394904/5/imgnlogo.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/lab-5740505_1920_5.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2087.jpeg)
![](https://mms.businesswire.com/media/20220225005018/en/1371024/5/imgnlogo.jpg)
ImmunoGen Reports Recent Progress and 2021 Financial Results
February 25, 2022
From ImmunoGen Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2075.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/ep_us_feature_image_981.jpeg)
![](https://mms.businesswire.com/media/20220223005063/en/1366019/5/imgnlogo.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3517.png)
![](https://mms.businesswire.com/media/20220215005481/en/1359614/5/imgnlogo.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech7.jpg)
![](https://mms.businesswire.com/media/20220210005022/en/1353773/5/imgnlogo.jpg)
From ImmunoGen Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220204005016/en/1346689/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220201005468/en/1345147/5/imgnlogo.jpg)
From ImmunoGen Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220131005121/en/1342961/5/imgnlogo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.